Posted by Michael Wonder on 16 Oct 2024
UroGen announces FDA acceptance of its new drug application for UGN-102
15 October 2024 - PDUFA goal date set for 13 June 2025.
UroGen Pharma today announced US FDA acceptance of the new drug application for investigational drug UGN-102 (mitomycin) for intravesical solution.
